Euronext Paris

Jérôme Vailland Joins 4P-Pharma as Chief Financial Officer

Retrieved on: 
Thursday, March 14, 2024

4P-Pharma, a clinical-stage biotech based in Lille dedicated to developing curative therapies for serious untreated diseases, is thrilled to announce the appointment of Jérôme Vailland as Chief Financial Officer (CFO) for 4P-Pharma and its subsidiaries.

Key Points: 
  • 4P-Pharma, a clinical-stage biotech based in Lille dedicated to developing curative therapies for serious untreated diseases, is thrilled to announce the appointment of Jérôme Vailland as Chief Financial Officer (CFO) for 4P-Pharma and its subsidiaries.
  • View the full release here: https://www.businesswire.com/news/home/20240314228336/en/
    Jérôme Vailland 4P-Pharma Chief Financial Officer (Photo: Business Wire)
    Jérôme Vailland built a solid career with significant contributions at Ernst & Young (EY), where he worked for 10+ years.
  • Following his strong experience at EY, Jérôme joined Horama, now Coave Therapeutics, in 2016, serving as Chief Financial Officer.
  • Regarding his appointment as Chief Financial Officer, Jérôme Vailland said, "I am thrilled to join 4P-Pharma at a decisive moment, especially with two drug candidates prepared to enter Phase II clinical trials.

Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 14, 2024

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 21, 2024 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2023.

Key Points: 
  • Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 21, 2024 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2023.
  • Participants during the call will be:
    The live webcast will be available at the following link:
    Participants may also join via telephone using the following registration link: https://registrations.events/direct/Q4I409542
    This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com .
  • A replay of the webcast will be available on the Company website for 90 days following the event.

Embraer Selects Dassault Systèmes’ Simulation Technology to Support Quieter eVTOL Aircraft Development for Eve Air Mobility

Retrieved on: 
Thursday, March 14, 2024

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Embraer (NYSE: ERJ; B3: EMBR3) announced today that Dassault Systèmes’ simulation technology has been utilized to simulate, analyze and test virtually Eve Air Mobility’s (NYSE: EVEX) electric vertical take-off and landing (eVTOL) aircraft.

Key Points: 
  • Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Embraer (NYSE: ERJ; B3: EMBR3) announced today that Dassault Systèmes’ simulation technology has been utilized to simulate, analyze and test virtually Eve Air Mobility’s (NYSE: EVEX) electric vertical take-off and landing (eVTOL) aircraft.
  • Dassault Systèmes’ SIMULIA PowerFLOW application has provided robust and industry-proven fluid dynamics simulation to predict real-world operating conditions, allowing Embraer and Eve’s engineers to evaluate how the aircraft flies and test its sound emission.
  • “One of the main advantages of eVTOL aircraft is that they are electrically powered and a more sustainable option than combustion-powered aircraft.
  • SIMULIA fluid dynamics applications will enable Embraer and Eve to experience and optimize the most critical parts of their eVTOL aircraft in a virtual environment,” said David Ziegler, Vice President, Aerospace & Defense Industry, Dassault Systèmes.

Dassault Systèmes and CDR-Life Collaborate to Accelerate Scientific Innovation for Cancer Therapies

Retrieved on: 
Tuesday, March 12, 2024

Scientists from Dassault Systèmes’ Contract Research team worked closely with scientists from CDR-Life to perform virtual “what if” experiments on antibody-based biologics called T-cell engagers, using Dassault Systèmes’ BIOVIA software and CDR-Life’s experimental data.

Key Points: 
  • Scientists from Dassault Systèmes’ Contract Research team worked closely with scientists from CDR-Life to perform virtual “what if” experiments on antibody-based biologics called T-cell engagers, using Dassault Systèmes’ BIOVIA software and CDR-Life’s experimental data.
  • “Our collaboration with Dassault Systèmes’ Contract Research team accelerated our research and development efforts based on our proprietary antibody-based MHC-targeting T-cell engager technology.
  • Pharmaceutical and biotechnology companies of all sizes seek to accelerate the development of therapies that will help people live healthier lives,” said Claire Biot, Vice President, Life Sciences & Healthcare Industry, Dassault Systèmes.
  • Dassault Systèmes’ 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com
    M-gager is a proprietary technology and registered trademark of CDR-Life.

Artmarket.com: the Artprice100© index was up 1.55% in 2023

Retrieved on: 
Thursday, April 4, 2024

"Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.

Key Points: 
  • "Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.
  • The exact breakdown of the portfolio as of 1 January 2023 is provided below in the section Composition of Artprice100© as of 1 January 2023.
  • The investment in works by Jean-Michel Basquiat (1960-1988) represented 3.9% of the portfolio at the start of 2023, but his price index fell by -15% in 2023.
  • Modern Art remained the largest segment in the composition of the Artprice100© index, accounting for 43% of the initial 2023 investment.

Artmarket.com: the Artprice100© index was up 1.55% in 2023

Retrieved on: 
Thursday, April 4, 2024

"Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.

Key Points: 
  • "Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.
  • The exact breakdown of the portfolio as of 1 January 2023 is provided below in the section Composition of Artprice100© as of 1 January 2023.
  • The investment in works by Jean-Michel Basquiat (1960-1988) represented 3.9% of the portfolio at the start of 2023, but his price index fell by -15% in 2023.
  • Modern Art remained the largest segment in the composition of the Artprice100© index, accounting for 43% of the initial 2023 investment.

Exclusive Networks announces a major step in its growth strategy in APAC with NEXTGEN Group acquisition

Retrieved on: 
Thursday, March 28, 2024

Headquartered in Sydney, Australia, NEXTGEN was founded in 2011 and has 190 employees across APAC.

Key Points: 
  • Headquartered in Sydney, Australia, NEXTGEN was founded in 2011 and has 190 employees across APAC.
  • In FY-23, ending June 30th, 2023, NEXTGEN generated Gross Sales of AU$266m (€160 m), with expected double-digit growth for the years to come.
  • This operation fits perfectly with Exclusive Networks' external growth strategy.
  • "This acquisition is a major step forward in our growth strategy in APAC, it significantly strengthens our business and allows us to expand and develop further our value proposition.

Teleperformance Citizen of the World philanthropy programs benefitted nearly 225,000 vulnerable people in 2023

Retrieved on: 
Tuesday, March 26, 2024

Over the past few years, people around the world have grappled with the impact of war and several natural disasters.

Key Points: 
  • Over the past few years, people around the world have grappled with the impact of war and several natural disasters.
  • Entire communities, schools, and families have suffered, and Teleperformance has worked closely with global and local organizations to provide aid and support .
  • Since its inception in 2006, the Teleperformance Citizen of the World program has made more than €70 million in cash and in-kind donations to help improve lives around the world, particularly vulnerable children and their families.
  • Teleperformance aided 46,000 people affected by the ongoing conflict in Sudan, through nutrition, vaccination and water sanitation programs for displaced children and families.

Ekinops Delivers 800G Solution, Doubles Capacity and Extends Reach

Retrieved on: 
Monday, March 25, 2024

With the market for 800G transport reaching critical mass, Ekinops now offers a high-performance solution capable of regional distances at full line rate and long-haul transport at 400G.

Key Points: 
  • With the market for 800G transport reaching critical mass, Ekinops now offers a high-performance solution capable of regional distances at full line rate and long-haul transport at 400G.
  • To date, 800G has been limited to early adopters, mainly Tier 1 service providers, looking to reduce the number of wavelengths they have to manage as capacity growth accelerates.
  • "The PM_800FR04 really serves multiple purposes in terms of our customers' needs for higher capacity transport," said Sylvain Quartier, Chief Marketing Officer at Ekinops.
  • For more information about the Ekinops portfolio, please visit https://www.ekinops.com/products-services/products
    All press releases are published after Euronext Paris market close.

Ekinops Expands North American Presence, Doubles Customer Base

Retrieved on: 
Tuesday, March 19, 2024

Tripling the size of its previous location, the new facility is the result of Ekinops continued success operating in North America.

Key Points: 
  • Tripling the size of its previous location, the new facility is the result of Ekinops continued success operating in North America.
  • Over the last three years, Ekinops has doubled its customer base and continues to demonstrate strong revenue growth.
  • The new facility will serve as Ekinops regional headquarters including its world-class customer service organization as well as the Ekinops Learning Center (ELC) that serves as its training facility for all North American customers.
  • Ekinops North American home for the past five years, Rockville, is conveniently located close to both Washington, DC and Baltimore, MD making it easily accessible to two major cities and three airports.